Alkermes Inc. plc (ALKS) News

Latest headlines that mention ALKS, newest first · each headline opens the original publisher

ALKS quote

Last price: $40.11
Day change: -3.22%
Next earnings: 2026-10-27

Quote & chart Expected move Insider trading IV rank history

ALKS headlines

last 30 days

Investing.com 3d ago

Stifel reiterates Alkermes stock rating on pipeline confidence

General T3ALKS SF

Seeking Alpha News 12d ago

Alkermes: Idiopathic Hypersomnia Could Expand Lumryz Into A Larger Growth And Margin Driver

General T2ALKS

Investing.com 14d ago

Goldman Sachs resumes Alkermes stock coverage with neutral rating

General T3ALKS GS

Seeking Alpha News 15d ago

Alkermes: The Orexin Upside Is Real, But Takeda And Lilly Stand In The Way (Downgrade)

General T2ALKS LLY TAK

IBD 17d ago

How Alkermes Used Its Narcolepsy Playbook In ADHD — And Seemingly Won

Alkermes stock jumped Monday on the first proof-of-concept for its orexin-modulating drug in adults with ADHD. The post How Alkermes Used Its Narcolepsy Playbook In ADHD — And Seemingly Won appeared first on Investor's Business Daily .

General T2ALKS

Seeking Alpha 20d ago

Alkermes slides 7%, reaching multi-month low

General T2ALKS

Seeking Alpha News 27d ago

Alkermes: A Slow-Burning Buy Prospect On Orexin-Agonist Promise

General T2ALKS

Also mentioned with ALKS

30d

Headlines that tag both tickers

ALKS news alerts

Get an alert by email or push when a new headline mentions ALKS.

More news

News headlines aggregated from third-party publishers via public RSS feeds and tagged with the tickers they mention. Frenzy Capital does not publish or endorse the content; clicking a headline opens the original publisher in a new tab.